News

As Seen In
RepliCel Poised To Partner Up For Precision-Control Dermal Injector
7 years ago Jul 22, 2017
To preview the interview with Tina Tan as it appears on Medtech.com, click here. (6/23/17)
As Seen In
Hair-Raising R&D: RepliCel Developing Autologous Cell Therapy for Baldness
7 years ago Jul 13, 2017
To read the full article as it appears on BioPharma-reporter.com, click here. (7/12/17) ...
As Seen In
Poised for Success with Positive Clinical Results
7 years ago Jul 05, 2017
To read the full interview as it appears on Costmeticosbr.com.br, click here (7/6/17).
As Seen In
A New Approach to Treating Hair Loss
7 years ago Jun 26, 2017
To read the full interview as it appears on Technologyworks.com, click here. (6/27/17)
As Seen In
Your Hair Could Hold The Secret To Mending Your Injured Tendon
7 years ago Jun 26, 2017
To read the full article as it appears on Pridenews.ca , click here (6/27/17)....
As Seen In
The Latest in Biocellular Regeneration
7 years ago Jun 19, 2017
To read the full article as it appears on TheAestheticChannel.com by Lisette Hilton, click here...
Press Release
RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map
7 years ago Jun 12, 2017
Data from this project expected to take RepliCel’s products to next level of potential commercial...
As Seen In
Pioneer in Both Biotech & Business Left Noteworthy Legacy
7 years ago Jun 08, 2017
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,...
As Seen In
Exclusive Interview with RepliCel Life Sciences President and CEO Lee Buckler
8 years ago Jun 07, 2017
To read the full article as it appears on SmarterAnalyst.com by Julie Lamb, click here....
As Seen In
Promise of Regenerative Medicine Already Upon Us
8 years ago Jun 05, 2017
To read the full article as it appears on HuffingtonPost.com by contributing editor, Lee Buckler,...
As Seen In
RepliCel Life Sciences gets price target raise at Echelon Wealth Partners
8 years ago May 29, 2017
To read the full article as it appears on Cantech Letters by Nick Waddell, click...
Press Release
RepliCel CEO Provides Company Outlook
8 years ago May 24, 2017
A data-rich 2017 positions RepliCel for maturity through the next phase of its product development,...
As Seen In
Cell therapy: Scientific breakthrough treats signs of ageing
8 years ago May 16, 2017
To read the full article as it appears on Cosmetics design-asia.com by Natasha Spencer, click...
As Seen In
RepliCel, cell therapy companies ready to give you athletic immortality
8 years ago May 13, 2017
To read the full article as it appears on Metro News by Matt Burke, click...
Press Release
United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies
8 years ago Apr 24, 2017
With exclusive U.S. rights to RCI-02 patents, RepliCel edges its nearest-term commercial asset closer to...
As Seen In
RepliCel Developing Autologous Cell Therapies For Skin, Hair and Tendon Regeneration
8 years ago Apr 21, 2017
To read the full interview as it appears on MedicalResearch.com, click here. (4/22/17)
As Seen In
String of Positive Trial Results Boosts RepliCel’s Profile
8 years ago Apr 11, 2017
To read the full article as it appears on thelifesciencesreport.com, click here. (04/12/17)
As Seen In
RepliCel – Stem Cell Therapies Using Your Own Cells
8 years ago Apr 09, 2017
To listen to Podcast and View Transcript on Future Tech Podcast, click here
As Seen In
Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis (ReaCT)
8 years ago Apr 06, 2017
To read the full study as it appears on ClinicalTrials.gov, click here. Source: Clinical Trials....
Press Release
Positive Results from RepliCel’s RCS-01 Phase I Skin Trial are the Company’s Most Compelling to Date
8 years ago Apr 03, 2017
Interim trial results lead researchers to conclude that the injection of RCS-01 is not only...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.